Ambeed.cn

首页 / / / 谷氨酰胺酶 / BPTES

BPTES

货号:A413914

BPTES通过变构调节表现出对谷氨酰胺酶的强效抑制作用,具有选择性,IC50 为 0.16 μM。

BPTES 化学结构 CAS号:314045-39-1
BPTES 化学结构
CAS号:314045-39-1
BPTES 3D分子结构
CAS号:314045-39-1
BPTES 化学结构 CAS号:314045-39-1
BPTES 3D分子结构 CAS号:314045-39-1
规格 价格 库存 数量
50μL*10mM(DMSO) ¥99随货¥69 咨询
100μL*10mM(DMSO) ¥139 咨询
250μL*10mM(DMSO) ¥259 咨询
500μL*10mM(DMSO) ¥369 咨询
10mM*1mL(DMSO) ¥582 咨询
1mg ¥182 咨询
5mg ¥454 咨询
10mg ¥599 咨询
25mg ¥1094 咨询
50mg ¥1688 咨询
1g ¥7585 咨询
购物车 收藏 询单

BPTES 纯度/质量文件 产品仅供科研

货号:A413914 标准纯度:
批次查询: 批次纯度:

全球学术期刊中引用的产品

ACS Appl. Nano Mater., 2025. Ambeed. [ A188026 ]
Eur. J. Clin. Microbiol. Infect. Dis., 2025. Ambeed. [ A151161 ]
JJC, 2025, 20(Special Issue)): 27-39. Ambeed. [ A713856 ]
bioRxiv, 2025. Ambeed. [ A538667 , A714873 , A126729 , A126049 , A446054 ]
Nature Communications, 2025, 16, 1871. Ambeed. [ A508148 ]
更多 >
产品名称 glutaminase 其他靶点 纯度
Telaglenastat +++

Glutaminase, IC50: 24 nM

99%+
BPTES ++

Glutaminase GLS1 (KGA), IC50: 0.16 μM

98%+
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

BPTES 生物活性

靶点
  • glutaminase

    Glutaminase GLS1 (KGA), IC50:0.16 μM

描述 Glutaminase (GLS) is responsible for the hydrolysis of glutamine into glutamate and ammonia. BPTES is a potent and selective allosteric inhibitor of kidney-type GLS (KGS) with an IC50 value of 3.3 ± 0.7 μM[6]. In both WT and mutant IDH1 expressing cells, BPTES at 10 μM resulted in 59% and 68% inhibition, respectively, of glutaminase activity. The administration of BPTES also diminished the levels of glutamate and α-KG. However, the levels of glycolytic intermediates, incudling fructose-1,6-bisphosphate, dihydroxy-acetone-phosphate, and 3-phosphoglycerate, were increased by BPTES treatment[7]. In P493 cells, BPTES at 2 - 20 μM effectively suppressed cell proliferation under both aerobic and hypoxic conditions. When P493 cells were treated by 2 μM BPTES for 20h, the steady state ATP levels were significantly downregulated compared to control cells under both normoxia and hypoxia. The administration of tumor-bearing SCID mice with BPTES (12.5 mg/kg, once every other day) for 20 days significantly diminished tumor progression compared to DMSO-treated group[8].

BPTES 动物研究

Dose Mice: 10 mg/kg[3] (p.o.); 12.5 mg/kg[4] (i.p.), 25 mg/kg[5] (i.p.) Rat: 2 mg/kg[5] (i.v.)
Administration p.o., i.p., i.v.
Pharmacokinetics
Animal Rats[5]
Dose 2.0 mg/kg (i.v.)
10 mg/kg (p.o.)
Administration i.v.
p.o.
F 2% (p.o.)
AUC0-inf 636 ± 90 (ng/ml)·h (i.v.)
73 ± 2 (ng/ml)·h (p.o.)
T1/2 5.3 ± 1.4 h (i.v.)
2.0 ± 0.1 h (p.o.)
Tmax 0.7 ± 0.3 h (p.o.)
CL 53 ± 7.6 ml/min/kg (i.v.)
Cmax 40 ± 8.2 ng/ml (p.o.)
Vss 8.8 ± 1.6 L/kg (i.v.)

BPTES 参考文献

[1]Xiang Y, Stine ZE, et al. Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis. J Clin Invest. 2015 Jun;125(6):2293-306.

[2]Seltzer MJ, Bennett BD, et al. Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1. Cancer Res. 2010 Nov 15;70(22):8981-7.

[3]Lee JS, Kang JH, et al. Dual targeting of glutaminase 1 and thymidylate synthase elicits death synergistically in NSCLC. Cell Death Dis. 2016 Dec 8;7(12):e2511.

[4]Elgogary A, Xu Q, et al. Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer. Proc Natl Acad Sci U S A. 2016 Sep 6;113(36):E5328-36.

[5]Yeh TK, Kuo CC, et al. Design, Synthesis, and Evaluation of Thiazolidine-2,4-dione Derivatives as a Novel Class of Glutaminase Inhibitors. J Med Chem. 2017 Jul 13;60(13):5599-5612.

[6]Shukla K, Ferraris DV, Thomas AG, Stathis M, Duvall B, Delahanty G, Alt J, Rais R, Rojas C, Gao P, Xiang Y, Dang CV, Slusher BS, Tsukamoto T. Design, synthesis, and pharmacological evaluation of bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide 3 (BPTES) analogs as glutaminase inhibitors. J Med Chem. 2012 Dec 13;55(23):10551-63. doi: 10.1021/jm301191p. Epub 2012 Nov 30. PMID: 23151085; PMCID: PMC3539823.

[7]Seltzer MJ, Bennett BD, Joshi AD, Gao P, Thomas AG, Ferraris DV, Tsukamoto T, Rojas CJ, Slusher BS, Rabinowitz JD, Dang CV, Riggins GJ. Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1. Cancer Res. 2010 Nov 15;70(22):8981-7. doi: 10.1158/0008-5472.CAN-10-1666. Epub 2010 Nov 2. PMID: 21045145; PMCID: PMC3058858.

[8]Le A, Lane AN, Hamaker M, Bose S, Gouw A, Barbi J, Tsukamoto T, Rojas CJ, Slusher BS, Zhang H, Zimmerman LJ, Liebler DC, Slebos RJ, Lorkiewicz PK, Higashi RM, Fan TW, Dang CV. Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. Cell Metab. 2012 Jan 4;15(1):110-21. doi: 10.1016/j.cmet.2011.12.009. PMID: 22225880; PMCID: PMC3345194.

BPTES 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.91mL

0.38mL

0.19mL

9.53mL

1.91mL

0.95mL

19.06mL

3.81mL

1.91mL

BPTES 技术信息

CAS号314045-39-1
分子式C24H24N6O2S3
分子量 524.681
别名
运输蓝冰
存储条件

In solvent -20°C:3-6个月-80°C:12个月

Pure form Sealed in dry,2-8°C

溶解方案

DMSO: 35 mg/mL(66.71 mM),配合低频超声,并水浴加热至45℃助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案一
方案二
动物实验配方
Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。